Bivalirudin (Dr. Reddy’s Laboratories Limited)


Welcome to the PulseAid listing for the Bivalirudin drug offered from Dr. Reddy’s Laboratories Limited. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dr. Reddy’s Laboratories Limited
NON-PROPRIETARY NAME: Bivalirudin
SUBSTANCE NAME: BIVALIRUDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRACAVERNOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-05-31
END MARKETING DATE: 0000-00-00


Bivalirudin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBivalirudin from Dr. Reddy’s Laboratories Limited
LABELER NAME: Dr. Reddy’s Laboratories Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2017-05-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55111-652_dcce401c-8b96-6ede-ae53-bf7b60d79f13
PRODUCT NDC: 55111-652
APPLICATION NUMBER: ANDA201577

Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex corpBivalirudin
Dr. Reddy’s Laboratories LimitedBivalirudin
Fresenius Kabi USA, LLCBivalirudin
Hospira, Inc.Bivalirudin
Sagent Pharmaceuticalsbivalirudin
Sandozbivalirudin
The Medicines CompanyAngiomax